These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8809331)
21. Histological grading, growth fraction and DNA-ploidy as criteria for the treatment of pharyngeal and supraglottic squamous cell carcinomas: a preliminary, prospective study. Jacob R; Welkoborsky HJ; Bittinger F; Mann WJ; Amedee R ORL J Otorhinolaryngol Relat Spec; 2001; 63(5):314-20. PubMed ID: 11528277 [TBL] [Abstract][Full Text] [Related]
22. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403 [TBL] [Abstract][Full Text] [Related]
23. Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression. Yamamoto M; Yoshida M; Ono K; Fujita T; Ohtani-Fujita N; Sakai T; Nikaido T Exp Cell Res; 1994 Jan; 210(1):94-101. PubMed ID: 8270002 [TBL] [Abstract][Full Text] [Related]
24. Heat shock protein and p53 expression in head and neck squamous cell carcinoma. Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858 [TBL] [Abstract][Full Text] [Related]
25. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Maestro R; Dolcetti R; Gasparotto D; Doglioni C; Pelucchi S; Barzan L; Grandi E; Boiocchi M Oncogene; 1992 Jun; 7(6):1159-66. PubMed ID: 1594246 [TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of DNA content in laryngeal squamous cell carcinoma in relation to histopathological variables. Ladika-Davidovic B; Coric M; Bura M; Brcic L; Kusic Z; Seiwerth S Acta Otolaryngol; 2009 Jul; 129(7):768-73. PubMed ID: 18766495 [TBL] [Abstract][Full Text] [Related]
27. Significance of ceramide and DNA ploidy in laryngeal carcinogenesis. Yuan Y; Chi F; Wang S; Wang Z ORL J Otorhinolaryngol Relat Spec; 2007; 69(5):283-8. PubMed ID: 17565231 [TBL] [Abstract][Full Text] [Related]
28. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer. Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532 [TBL] [Abstract][Full Text] [Related]
29. [Expression of P53 protein in premalignant lesion and carcinoma of larynx]. Zhou G; Lin D; Liang C; Zhang X; Wen D; Liu Y Hua Xi Yi Ke Da Xue Xue Bao; 1999 Sep; 30(3):265-7. PubMed ID: 12212278 [TBL] [Abstract][Full Text] [Related]
30. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx. Griffin MC; Robinson RA; Trask DK Mod Pathol; 2003 Dec; 16(12):1181-8. PubMed ID: 14681317 [TBL] [Abstract][Full Text] [Related]
31. Over-expression of p53 protein in human laryngeal carcinoma. Anwar K; Nakakuki K; Imai H; Naiki H; Inuzuka M Int J Cancer; 1993 Apr; 53(6):952-6. PubMed ID: 8386140 [TBL] [Abstract][Full Text] [Related]
32. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma. Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904 [TBL] [Abstract][Full Text] [Related]
33. Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk. Jeannon JP; Soames JV; Aston V; Stafford FW; Wilson JA Clin Otolaryngol Allied Sci; 2004 Dec; 29(6):698-704. PubMed ID: 15533163 [TBL] [Abstract][Full Text] [Related]
34. [Comparative study of histology and flow cytometry results obtained in 2 groups of laryngeal tumors, glottic and supraglottic, in T-1 stage]. Barona R; Martorell MA; Basterra J; Garín L; Armengot M Acta Otorrinolaringol Esp; 1992; 43(6):401-6. PubMed ID: 1299280 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of p53 nuclear protein in premalignant and malignant laryngeal lesions. Nakashima T; Wang XF; Masuda M; Inokuchi A; Komiyama S Eur Arch Otorhinolaryngol; 1999; 256 Suppl 1():S56-9. PubMed ID: 10337529 [TBL] [Abstract][Full Text] [Related]
36. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings]. Esser D; Anke S; Roessner A; Freigang B Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912 [TBL] [Abstract][Full Text] [Related]
37. Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Soder AI; Hopman AH; Ramaekers FC; Conradt C; Bosch FX Cancer Res; 1995 Nov; 55(21):5030-7. PubMed ID: 7585547 [TBL] [Abstract][Full Text] [Related]
38. P53/MDM2 Co-Expression in Laryngeal Squamous Cell Carcinoma Based on Digital Image Analysis. Chrysovergis A; Papanikolaou V; Tsiambas E; Stavraka C; Ragos V; Peschos D; Psyrri A; Mastronikolis N; Kyrodimos E Anticancer Res; 2019 Aug; 39(8):4137-4142. PubMed ID: 31366498 [TBL] [Abstract][Full Text] [Related]
39. Prognostic value of PCNA and mutant p53 expression in laryngeal squamous cell carcinoma. Buyukbayram H; Cureoglu S; Arslan A; Işikakdogan AR Cancer Invest; 2004; 22(2):195-202. PubMed ID: 15199601 [TBL] [Abstract][Full Text] [Related]
40. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck. Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]